vs
Apellis Pharmaceuticals, Inc.（APLS）与POTLATCHDELTIC CORP（PCH）财务数据对比。点击上方公司名可切换其他公司
POTLATCHDELTIC CORP的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$314.2M vs $199.9M），POTLATCHDELTIC CORP净利率更高（8.2% vs -29.5%，领先37.7%），POTLATCHDELTIC CORP同比增速更快（23.1% vs -5.9%），POTLATCHDELTIC CORP自由现金流更多（$50.1M vs $-14.3M），过去两年POTLATCHDELTIC CORP的营收复合增速更高（11.1% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
PotlatchDeltic是一家总部位于美国华盛顿州斯波坎的多元化林产品企业，业务覆盖林木培育、木材加工及相关林制品的生产与供应，在林业资源管理和产品研发领域拥有成熟的运营体系，为建筑、家居等多个下游行业提供优质原材料与产品解决方案。
APLS vs PCH — 直观对比
营收规模更大
PCH
是对方的1.6倍
$199.9M
营收增速更快
PCH
高出29.1%
-5.9%
净利率更高
PCH
高出37.7%
-29.5%
自由现金流更多
PCH
多$64.4M
$-14.3M
两年增速更快
PCH
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $314.2M |
| 净利润 | $-59.0M | $25.9M |
| 毛利率 | — | 18.2% |
| 营业利润率 | -25.6% | 11.2% |
| 净利率 | -29.5% | 8.2% |
| 营收同比 | -5.9% | 23.1% |
| 净利润同比 | -62.2% | 682.5% |
| 每股收益（稀释后） | $-0.40 | $0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSPCH
| Q4 25 | $199.9M | — | ||
| Q3 25 | $458.6M | $314.2M | ||
| Q2 25 | $178.5M | $275.0M | ||
| Q1 25 | $166.8M | $268.3M | ||
| Q4 24 | $212.5M | $258.1M | ||
| Q3 24 | $196.8M | $255.1M | ||
| Q2 24 | $199.7M | $320.7M | ||
| Q1 24 | $172.3M | $228.1M |
净利润APLSPCH
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $25.9M | ||
| Q2 25 | $-42.2M | $7.4M | ||
| Q1 25 | $-92.2M | $25.8M | ||
| Q4 24 | $-36.4M | $5.2M | ||
| Q3 24 | $-57.4M | $3.3M | ||
| Q2 24 | $-37.7M | $13.7M | ||
| Q1 24 | $-66.4M | $-305.0K |
毛利率APLSPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 13.0% | ||
| Q1 25 | — | 17.8% | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | 7.0% |
营业利润率APLSPCH
| Q4 25 | -25.6% | — | ||
| Q3 25 | 48.7% | 11.2% | ||
| Q2 25 | -18.6% | 5.0% | ||
| Q1 25 | -50.0% | 10.3% | ||
| Q4 24 | -12.3% | 5.2% | ||
| Q3 24 | -24.0% | 2.8% | ||
| Q2 24 | -14.7% | 5.4% | ||
| Q1 24 | -36.0% | -2.1% |
净利率APLSPCH
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | 8.2% | ||
| Q2 25 | -23.6% | 2.7% | ||
| Q1 25 | -55.3% | 9.6% | ||
| Q4 24 | -17.1% | 2.0% | ||
| Q3 24 | -29.2% | 1.3% | ||
| Q2 24 | -18.9% | 4.3% | ||
| Q1 24 | -38.5% | -0.1% |
每股收益（稀释后）APLSPCH
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | $0.33 | ||
| Q2 25 | $-0.33 | $0.09 | ||
| Q1 25 | $-0.74 | $0.33 | ||
| Q4 24 | $-0.30 | $0.07 | ||
| Q3 24 | $-0.46 | $0.04 | ||
| Q2 24 | $-0.30 | $0.17 | ||
| Q1 24 | $-0.54 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $88.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $1.9B |
| 总资产 | $1.1B | $3.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSPCH
| Q4 25 | $466.2M | — | ||
| Q3 25 | $479.2M | $88.8M | ||
| Q2 25 | $370.0M | $95.3M | ||
| Q1 25 | $358.4M | $147.5M | ||
| Q4 24 | $411.3M | $151.6M | ||
| Q3 24 | $396.9M | $161.1M | ||
| Q2 24 | $360.1M | $199.7M | ||
| Q1 24 | $325.9M | $180.2M |
总债务APLSPCH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSPCH
| Q4 25 | $370.1M | — | ||
| Q3 25 | $401.2M | $1.9B | ||
| Q2 25 | $156.3M | $1.9B | ||
| Q1 25 | $164.2M | $2.0B | ||
| Q4 24 | $228.5M | $2.0B | ||
| Q3 24 | $237.1M | $2.1B | ||
| Q2 24 | $264.3M | $2.1B | ||
| Q1 24 | $266.7M | $2.2B |
总资产APLSPCH
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $3.2B | ||
| Q2 25 | $821.4M | $3.2B | ||
| Q1 25 | $807.3M | $3.3B | ||
| Q4 24 | $885.1M | $3.3B | ||
| Q3 24 | $901.9M | $3.3B | ||
| Q2 24 | $904.5M | $3.4B | ||
| Q1 24 | $831.9M | $3.4B |
负债/权益比APLSPCH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $65.7M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $50.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 15.9% |
| 资本支出强度资本支出/营收 | 0.1% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 2.54× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $132.4M |
8季度趋势，按日历期对齐
经营现金流APLSPCH
| Q4 25 | $-14.2M | — | ||
| Q3 25 | $108.5M | $65.7M | ||
| Q2 25 | $4.4M | $41.0M | ||
| Q1 25 | $-53.4M | $49.1M | ||
| Q4 24 | $19.4M | $45.4M | ||
| Q3 24 | $34.1M | $26.5M | ||
| Q2 24 | $-8.3M | $100.6M | ||
| Q1 24 | $-133.0M | $16.0M |
自由现金流APLSPCH
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | $50.1M | ||
| Q2 25 | $4.4M | $30.6M | ||
| Q1 25 | $-53.4M | $26.3M | ||
| Q4 24 | $19.3M | $25.4M | ||
| Q3 24 | — | $-8.2M | ||
| Q2 24 | $-8.4M | $72.4M | ||
| Q1 24 | $-133.3M | $2.0M |
自由现金流率APLSPCH
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | 15.9% | ||
| Q2 25 | 2.5% | 11.1% | ||
| Q1 25 | -32.0% | 9.8% | ||
| Q4 24 | 9.1% | 9.9% | ||
| Q3 24 | — | -3.2% | ||
| Q2 24 | -4.2% | 22.6% | ||
| Q1 24 | -77.3% | 0.9% |
资本支出强度APLSPCH
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | 4.9% | ||
| Q2 25 | 0.0% | 3.8% | ||
| Q1 25 | 0.0% | 8.5% | ||
| Q4 24 | 0.0% | 7.7% | ||
| Q3 24 | 0.0% | 13.6% | ||
| Q2 24 | 0.0% | 8.8% | ||
| Q1 24 | 0.2% | 6.1% |
现金转化率APLSPCH
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.54× | ||
| Q2 25 | — | 5.58× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 8.74× | ||
| Q3 24 | — | 7.99× | ||
| Q2 24 | — | 7.35× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
